ARTICLE | Company News
Transposagen Biopharmaceuticals, J&J, Poseida Therapeutics deal
June 15, 2015 7:00 AM UTC
Transposagen transferred its gene editing technologies and related IP to its new spinout, Poseida. Transposagen also transferred to Poseida a November 2014 deal with Johnson & Johnson’s Janssen Pharma...